ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,183Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 890

$657K Total Retail Price of All Prescriptions

Rank: 166 out of 890

700 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 700 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

21% of this provider’s 700 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 667 530 1 5
HYDROCODONE-ACETAMINOPHEN 623 474 S3 2 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 563 388 3 21
LEVOTHYROXINE SODIUM 485 384 4 2
METFORMIN HCL 467 377 5 6
DEXAMETHASONE 467 359 10 5 264
FUROSEMIDE 440 346 7 7
TRAMADOL HCL 403 251 8 16
OMEPRAZOLE 361 254 9 8
AMLODIPINE BESYLATE 344 285 10 1
LISINOPRIL 338 274 11 4
CITALOPRAM HBR 314 263 12 20
POTASSIUM CHLORIDE 279 236 13 11
ZOLPIDEM TARTRATE 271 208 14 19
MELOXICAM 260 180 15 18
NEXIUM 251 100 16 14
GABAPENTIN 250 204 17 12
GLIMEPIRIDE 223 179 18 27
PRAVASTATIN SODIUM 213 165 19 10
ATENOLOL-CHLORTHALIDONE 206 147 20 147
PROAIR HFA 189 114 21 55
ATENOLOL 188 131 22 23
METOPROLOL TARTRATE 179 158 23 15
AMITRIPTYLINE HCL 178 114 R 24 43
ALLOPURINOL 175 133 25 31
METOPROLOL SUCCINATE 167 131 26 17
AMOX TR-POTASSIUM CLAVULANATE 161 132 27 132
AMLODIPINE BESYLATE-BENAZEPRIL 156 125 28 41
DOXYCYCLINE HYCLATE 150 102 29 89
CRESTOR 143 129 30 25
CIPROFLOXACIN HCL 140 117 31 58
PANTOPRAZOLE SODIUM 138 125 32 34
SYNTHROID 135 117 33 53
TIZANIDINE HCL 127 106 34 106
ATORVASTATIN CALCIUM 124 101 35 13
ETODOLAC 112 76 36 197
PREDNISONE 111 76 37 47
DIOVAN HCT 109 61 38 48
TRAZODONE HCL 109 39 38 40
AZITHROMYCIN 109 69 38 37
SERTRALINE HCL 104 79 41 26
CEPHALEXIN 101 73 42 119
ALPRAZOLAM 98 69 43 95
AMOXICILLIN 96 53 44 94
SPIRIVA 96 57 44 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 69 46 76
MUPIROCIN 93 72 47 121
DIGOXIN 90 70 48 65
ROPINIROLE HCL 90 68 48 93
PROPRANOLOL HCL 86 66 50 141
TRIAMTERENE-HYDROCHLOROTHIAZID 85 51 51 237
DICLOFENAC SODIUM 85 69 51 96
DONEPEZIL HCL 83 72 53 30
CLOPIDOGREL 83 72 53 28
CYMBALTA 82 53 55 45
MECLIZINE HCL 80 73 56 97
METHYLPREDNISOLONE 78 58 57 109
VENTOLIN HFA 78 51 57 177
ESCITALOPRAM OXALATE 73 51 59 51
LACTULOSE 72 72 60 112
TAMSULOSIN HCL 68 56 61 32
IBUPROFEN 67 31 62 101
WARFARIN SODIUM 66 46 63 24
ADVAIR DISKUS 66 34 63 52
LOVASTATIN 63 42 65 46
LANTUS 62 62 66 50
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 67 57
TRIAMTERENE-HCTZ 60 51 68 61
GLIPIZIDE XL 60 55 68 128
BENICAR HCT 59 59 70 166
INSULIN SYRINGE 59 59 70 99
CARVEDILOL 58 48 72 22
HYDROCHLOROTHIAZIDE 57 42 73 9
CLOTRIMAZOLE-BETAMETHASONE 56 41 74 152
PLAVIX 55 49 75 42
LOSARTAN POTASSIUM 54 54 76 29
CYCLOBENZAPRINE HCL 54 0 R 76 64
METOCLOPRAMIDE HCL 53 32 78 125
PROMETHAZINE HCL 53 0 R 78 104
CLONIDINE HCL 50 35 80 35
FLUTICASONE PROPIONATE 50 33 80 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.